Zai Labs Stock: Biopharma's Alibaba, But Better (NASDAQ:ZLAB)
Zai Labs is a relative new entrant to the Chinese pharma space and has multiple approvals and a large clinical pipeline. Read more on ZLAB here.
Source: seekingalpha.com
Stay updated with breaking news from While Zai Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Zai Labs is a relative new entrant to the Chinese pharma space and has multiple approvals and a large clinical pipeline. Read more on ZLAB here.